Novo Nordisk A/S Common Stock · Other Income/Expenses (Net)

Latest reportedkr 6.65B DKKperiod endingJun 30, 2026

NVO Other Income/Expenses (Net) · DKK (kr 143.42M → kr 6.65B)

Annual Other Income/Expenses (Net)

High-resolution chart · PNG

NVO other income/expenses (net) history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Other Income/Expenses (Net) — Annual fiscal periods (DKK)
Period ending	Other Income/Expenses (Net) (DKK)
Dec 31, 2025	2,882,000,000
Dec 31, 2024	-1,148,000,000
Dec 31, 2023	2,100,000,000
Dec 31, 2022	-5,747,000,000
Dec 31, 2021	436,000,000
Dec 31, 2020	-996,000,000
Dec 31, 2019	-3,930,000,000
Dec 31, 2018	367,000,000
Dec 31, 2017	-287,000,000
Dec 31, 2016	-634,000,000
Dec 31, 2015	-5,961,000,000
Dec 31, 2014	-396,000,000
Dec 31, 2013	1,046,000,000
Dec 31, 2012	-1,663,000,000
Dec 31, 2011	-449,000,000
Dec 31, 2010	-605,000,000
Dec 31, 2009	-945,000,000
Dec 31, 2008	320,952,000
Dec 31, 2007	2,030,258,000
Dec 31, 2006	45,205,000
Dec 31, 2005	144,992,000
Dec 31, 2004	477,439,000
Dec 31, 2003	1,176,627,000
Dec 31, 2002	318,496,000
Dec 31, 2001	417,701,000
Dec 31, 2000	601,590,000
Dec 31, 1999	436,188,000
Dec 31, 1998	1,745,111,000
Dec 31, 1997	837,391,000
Dec 31, 1996	549,218,000
Dec 31, 1995	281,534,000
Dec 31, 1994	91,214,000
Dec 31, 1993	-72,027,000
Dec 31, 1992	514,345,000
Dec 31, 1991	58,543,650
Dec 31, 1990	85,484,800
Dec 31, 1989	-660,750
Dec 31, 1988	-30,933,000
Dec 31, 1987	49,991,300
Dec 31, 1986	119,682,750
Dec 31, 1985	143,424,000